简易血管质量倡议衰弱评分对静脉性腿溃疡愈合与复发的影响
本研究回顾2012至2024年534例活动性静脉性腿溃疡患者,用简易血管质量倡议衰弱评分(sVQI-FS)评估衰弱,发现43%为衰弱;衰弱与转诊延迟、溃疡更重相关,并显著降低24周愈合率及1年、3年无复发率。
要点
- sVQI-FS评分≥0.3定义衰弱,本研究43%的静脉性腿溃疡患者为衰弱。
- 衰弱患者转诊间隔更长、溃疡持续时间更久且溃疡更严重。
- 衰弱患者24周愈合率及1年、3年无复发率均显著低于非衰弱患者。
核心结论
- 衰弱显著影响静脉性腿溃疡患者的早期转诊,与更严重的溃疡相关,并影响溃疡愈合率和复发率。
研究设计与样本
- 回顾性分析2012至2024年534例活动性静脉性腿溃疡患者,年龄67±9岁,61%为女性。
- 纳入标准为活动性静脉性腿溃疡、存在浅表主干静脉反流且 duplex 超声无全深静脉功能不全。
- 衰弱采用sVQI-FS评估,评分≥0.3定义为衰弱。
主要发现
- 衰弱患者溃疡持续时间更长(7.1±0.9 vs. 4.7±1.1个月,p=0.001),转诊间隔更长(5.6±1.2 vs. 3.9±1.1个月,p=0.001)。
- 衰弱患者伤口床评分更严重(非衰弱 vs. 衰弱:11±3 vs. 15±5,p=0.001)。
- 衰弱组治疗强度(计划及非计划门诊访视与所有干预之和)是非衰弱组的1.8倍(p=0.001)。
- 12周初始愈合率非衰弱组26±2%、衰弱组16±2%(p=0.001);24周分别为67±4%和38±4%(p=0.003)。
- 1年无复发率非衰弱组59±4%、衰弱组36±5%(p=0.002);3年分别为30±6%和18±7%(p=0.002)。
关键数值与推荐
- sVQI-FS包含充血性心力衰竭、肾功能损害、慢性阻塞性肺疾病、不住在家中、不能行走、贫血及BMI低于18.5的体重不足状态。
- sVQI-FS评分≥0.3视为衰弱。
临床怎么用
- 对静脉性腿溃疡患者应评估衰弱,识别sVQI-FS≥0.3者以尽早转诊和干预。
- 衰弱患者需更高治疗强度,应预期愈合率更低且复发风险更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Up to 1% of patients with chronic venous disease will present with a primary venous Leg Ulcer (VLU). This study aimed to analyze the impact of frailty as measured by the Simple Vascular Quality Initiative-Frailty Score (sVQI-FS) on the outcomes of patients undergoing treatment for a VLU. METHODS: Between 2012 and 2024, all patients presenting with a VLU were analyzed. Inclusion criteria were an active VLU, in the presence of superficial truncal venous incompetence, and without total deep venous incompetence (classified as involving all 18 named venous segments) on duplex imaging. Frailty was assessed by the sVQI-FS (congestive heart failure, renal impairment, chronic obstructive pulmonary disease, not living at home, not ambulatory, anemia, and underweight status with a BMI of less than 18.5). An sVQI-FS score of 0.3 or greater was considered frail. Demographics and interventions to effect healing were recorded. The primary outcomes were ulcer healing at 24 weeks and VLU recurrence within one year. RESULTS: 534 patients (61% female, age 67 ± 9 years, mean ± SD) presented with an active VLU. 43% of patients were classified as frail by the sVQI-FS. 31% had their ulcer for >12 months. Frail patients were more likely to have longer ulcer duration (7.1 ± 0.9 vs. 4.7 ± 1.1 months; Frail vs. Non-Frail; Mean ± SD; p=0.001) and have a longer interval before referral compared to non-frail patients (5.6 ± 1.2 vs. 3.9 ± 1.1 months, mean ± SD; p=0.001). Frailty was associated with more severe ulcers as measured by wound bed scores (11 ± 3 vs. 15 ± 5; Non-Frail vs. Frail; Mean ± SD; Frail vs. Non-Frail; p=0.001). The intensity of therapy, as measured by the sum of scheduled and unscheduled clinic visits and all interventions, was 1.8 times higher in the frail group than in the Non-Frail group (p = 0.001). Initial VLU healing was 26 ± 2% and 16 ± 2% at 12 weeks for Non-Frail and Frail, respectively (mean ± SEM; p=0.001). By 24 weeks, initial VLU healing was 67 ± 4% and 38 ± 4%, for Non-Frail and Frail, respectively (p=0.003). Freedom from VLU recurrence was 59 ± 4% and 36 ± 5% at 1 year (mean ± SEM; p=0.002). and 30 ± 6%, and 18 ± 7% at 3 years for Non Frail and Frail, respectively (p=0.002). CONCLUSIONS: Frailty significantly affects early referral for VLU care, is associated with more severe ulcers, and impacts both VLU healing rates and recurrence rates. Intervening to identify and ameliorate frailty is necessary to enhance VLU care.
引用
- Hart JP, Li M, Davies MG, et al. Impact of Simple Vascular Quality Initiative Frailty Score on Outcomes of Venous Leg Ulcer Healing and Recurrence. Ann Vasc Surg. 2026. PMID: 42863661. doi:10.1016/j.avsg.2026.09.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。